Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines
The predictive value of thymidine phosphorylase gene variants (TP, also called platelet-derived endothelial cell growth factor) and thrombocytosis were controversial and worthy of further study in gastrointestinal cancer (GIC) patients. We screened all of the common missense single nucleotide polymo...
Main Authors: | Huang, Liu, Chen, Fengju, Chen, Yangyang, Yang, Xiaomei, Xu, Sanpeng, Ge, Shuwang, Fu, Shengling, Chao, Tengfei, Yu, Qianqian, Liao, Xin, Hu, Guangyuan, Zhang, Peng, Yuan, Xianglin |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100023/ |
Similar Items
-
Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection
by: Huang, Liu, et al.
Published: (2016) -
Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.
by: Heldin, N. E., et al.
Published: (1993) -
Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
by: Griffiths, L., et al.
Published: (1997) -
Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.
by: Maeda, K., et al.
Published: (1996) -
The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.
by: Fox, S. B., et al.
Published: (1996)